As the popularity of prescription weight loss medications, including glucagon-like peptide-1 receptor agonists like Ozempic, continues to grow, the discussions around obesity care in the U.S. have started to shift.
The gastroenterology industry has experienced an increase in colonoscopy demand as the recommended age for screening continues to lower and colorectal cancer cases continue to rise.
Approximately 31% of gastroenterologists have a net worth of over $5 million in 2024, according to Medscape’s 2024 “Physician Wealth and Debt Report,” published June 12.
Two ASCs affiliated with GI physician practice management organization United Digestive have been named among U.S. News & World Report’s top ASCs in the nation for 2024.